Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
Citi
Harvard Business School
Accenture
Boehringer Ingelheim
Deloitte
McKinsey
Moodys
Chinese Patent Office

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,067,427

« Back to Dashboard

Summary for Patent: 8,067,427
Title:Pharmaceutical compositions comprising ZD6474
Abstract: A pharmaceutical composition comprising ZD6474 or a pharmaceutically acceptable salt thereof, a brittle diluent and a second diluent which is practically insoluble and has ductile compression properties.
Inventor(s): Stott; Paul William (Wilmington, DE)
Assignee: AstraZeneca AB (Sodertajle, SE)
Application Number:11/596,979
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 8,067,427

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Genzyme Corp CAPRELSA vandetanib TABLET;ORAL 022405-001 Apr 6, 2011 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Genzyme Corp CAPRELSA vandetanib TABLET;ORAL 022405-002 Apr 6, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,067,427

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0411378.3May 21, 2004
PCT Information
PCT FiledMay 18, 2005PCT Application Number:PCT/GB2005/001931
PCT Publication Date:December 01, 2005PCT Publication Number: WO2005/112934

International Patents Family Members for US Patent 8,067,427

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
South Korea 20070034499 ➤ Sign Up
Japan 4740947 ➤ Sign Up
Japan 2007538060 ➤ Sign Up
Israel 178928 ➤ Sign Up
European Patent Office 1753431 ➤ Sign Up
Spain 2330025 ➤ Sign Up
United Kingdom 0411378 ➤ Sign Up
Hong Kong 1099220 ➤ Sign Up
Croatia P20090547 ➤ Sign Up
South Korea 101192935 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
UBS
Merck
McKinsey
Boehringer Ingelheim
Covington
Cerilliant
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot